These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7703142)

  • 1. Immunodeficiency and new treatment for HBV.
    Benhamou Y
    Nurs Stand; 1995 Mar 1-7; 9(23):14. PubMed ID: 7703142
    [No Abstract]   [Full Text] [Related]  

  • 2. Lamivudine useful against hepatitis B-HIV co-infection.
    Prescott LM
    J Int Assoc Physicians AIDS Care; 1995 Jun; 1(5):34. PubMed ID: 11362610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quarter-century of antiviral therapy.
    Merigan TC
    N Engl J Med; 1995 Dec; 333(25):1704-5. PubMed ID: 7477225
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.
    Jain MK; Comanor L; White C; Kipnis P; Elkin C; Leung K; Ocampo A; Attar N; Keiser P; Lee WM
    J Viral Hepat; 2007 Mar; 14(3):176-82. PubMed ID: 17305883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients.
    Benhamou Y; Dohin E; Lunel-Fabiani F; Poynard T; Huraux JM; Katlama C; Opolon P; Gentilini M
    Lancet; 1995 Feb; 345(8946):396-7. PubMed ID: 7845151
    [No Abstract]   [Full Text] [Related]  

  • 6. Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating Committee.
    Dore GJ; Cooper DA; Barrett C; Goh LE; Thakrar B; Atkins M
    J Infect Dis; 1999 Sep; 180(3):607-13. PubMed ID: 10438346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamivudine as adjunct therapy in HIV.
    Am Fam Physician; 1996 Feb; 53(2):781-2. PubMed ID: 8629550
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis B: the other hepatitis virus. Treatment for HBV.
    Learned J
    Posit Aware; 2006; 17(3):30-2. PubMed ID: 16791961
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects.
    Puoti M; Airoldi M; Bruno R; Zanini B; Spinetti A; Pezzoli C; Patroni A; Castelli F; Sacchi P; Filice G; Carosi G
    AIDS Rev; 2002; 4(1):27-35. PubMed ID: 11998781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Update on the treatment of hepatitis B virus infection in patients infected by the human immunodeficiency virus].
    Benhamou Y
    Med Mal Infect; 2004 Nov; 34 Spec No 2():27-9. PubMed ID: 15801538
    [No Abstract]   [Full Text] [Related]  

  • 11. Lamivudine: a magic bullet for chronic hepatitis B?
    Grimm I
    Gastroenterology; 1996 Jul; 111(1):262-4. PubMed ID: 8698214
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C and B viruses: the new opportunists in HIV infection.
    Chung RT
    Top HIV Med; 2006; 14(2):78-83. PubMed ID: 16835462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ninety-six-week efficacy of combination therapy with lamivudine and tenofovir in patients coinfected with HIV-1 and wild-type hepatitis B virus.
    Bani-Sadr F; Palmer P; Scieux C; Molina JM
    Clin Infect Dis; 2004 Oct; 39(7):1062-4. PubMed ID: 15472862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients.
    Benhamou Y; Fleury H; Trimoulet P; Pellegrin I; Urbinelli R; Katlama C; Rozenbaum W; Le Teuff G; Trylesinski A; Piketty C;
    Hepatology; 2006 Mar; 43(3):548-55. PubMed ID: 16496322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy.
    Filippini P; Coppola N; Pisapia R; Scolastico C; Marrocco C; Zaccariello A; Nacca C; Sagnelli C; De Stefano G; Ferraro T; De Stefano C; Sagnelli E
    AIDS; 2006 Jun; 20(9):1253-60. PubMed ID: 16816553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Entecavir in HIV/HBV coinfection: possible HIV activity and resistance risk.
    AIDS Clin Care; 2007 Apr; 19(4):32. PubMed ID: 17695090
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of HBV/HIV-coinfected Patients.
    Shire NJ; Sherman KE
    Semin Liver Dis; 2005; 25 Suppl 1():48-57. PubMed ID: 16103981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A closer look at 3TC. Interview by Mark Mascolini.
    Rubin M
    J Int Assoc Physicians AIDS Care; 1995 Jul; 1(6):21-5. PubMed ID: 11362724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B reactivation after lamivudine.
    Honkoop P; de Man RA; Heijtink RA; Schalm SW
    Lancet; 1995 Oct; 346(8983):1156-7. PubMed ID: 7475613
    [No Abstract]   [Full Text] [Related]  

  • 20. [HIV-HBV-coinfection--diagnosis and therapy].
    Koch S; Göbels K; Oette M; Heintges T; Erhardt A; Häussinger D
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1873-7. PubMed ID: 16915550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.